Alere Press Room: Press Releases
Alere is leading the industry in informed, connected healthcare. Explore our press room to see how.
-
Alere Rapid Flu Test Receives CLIA Waiver from FDA
Alere Rapid Flu Test Receives CLIA Waiver from FDA -
Alere Pima™ CD4 Test receives prequalification from the World Health Organization
Alere Pima™ CD4 Test receives prequalification from the World Health Organization -
ALERE INC.DECLARES CASH DIVIDEND ON ITS SERIES B CONVERTIBLE PERPETUAL PREFERRED STOCK
ALERE INC.DECLARES CASH DIVIDEND ON ITS SERIES B CONVERTIBLE PERPETUAL PREFERRED STOCK -
Alere partners with global health nonprofit PSI to donate up to one million HIV tests
Alere partners with global health nonprofit PSI to donate up to one million HIV tests -
Alere Acquires Arriva Medical
Alere Acquires Arriva Medical -
Alere Inc. Statement Regarding Compulsory Acquisition of Outstanding Axis-Shield Shares
Alere Inc. Statement Regarding Compulsory Acquisition of Outstanding Axis-Shield Shares -
Alere Announces that Conditions to Offer to Acquire Axis Shield Have Been Satisfied or Waived
Alere Announces that Conditions to Offer to Acquire Axis Shield Have Been Satisfied or Waived -
Announcement of Posting of Revised Offer Document
October 10, 2011 -
Alere Inc. Statement Regarding Recommended Increased Cash Offer to Acquire Axis-Shield
Alere Inc. Statement Regarding Recommended Increased Cash Offer to Acquire Axis-Shield -
Alere Inc. Statement Regarding Axis-Shield Offer
Alere Inc. Statement Regarding Axis-Shield Offer -
HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions & Better Management of Heart Failure Patient
HABIT Study Highlights Home BNP Testing May Allow for Earlier Interventions & Better Management of Heart Failure Patient -
Rule 8.1 Announcement Regarding Ownership of Axis-Shield Shares
Rule 8.1 Announcement Regarding Ownership of Axis-Shield Shares -
ALERE ACQUIRES ADDITIONAL SHARES OF AXIS-SHIELD
ALERE ACQUIRES ADDITIONAL SHARES OF AXIS-SHIELD -
Alere Inc. Statement Regarding Axis-Shield Offer
Alere Inc. Statement Regarding Axis-Shield Offer -
Alere Inc. Statement Amending Acceptance Condition to Axis Shield Offer
Alere Inc. Statement Amending Acceptance Condition to Axis Shield Offer -
Alere to Attend the Jefferies 2011 Global Healthcare Conference on September 28, 2011
Alere to Attend the Jefferies 2011 Global Healthcare Conference on September 28, 2011 -
ALERE INC. STATEMENT REGARDING AXIS-SHIELD
ALERE INC. STATEMENT REGARDING AXIS-SHIELD -
Alere to Attend the Sixth Annual JMP Securities Healthcare Conference on September 27, 2011
Alere to Attend the Sixth Annual JMP Securities Healthcare Conference on September 27, 2011 -
ALERE ACQUIRES ADDITIONAL SHARES OF AXIS-SHIELD
ALERE ACQUIRES ADDITIONAL SHARES OF AXIS-SHIELD -
Alere Inc. Announces Second Closing Date Acceptances under Cash Offer to Acquire Axis Shield PLC
Alere Inc. Announces Second Closing Date Acceptances under Cash Offer to Acquire Axis Shield PLC -
Alere to Attend the 2011 Morgan Stanley Global Healthcare Conference on September 13, 2011
Alere to Attend the 2011 Morgan Stanley Global Healthcare Conference on September 13, 2011 -
ALERE INC. DECLARES CASH DIVIDEND
ALERE INC. DECLARES CASH DIVIDEND -
Alere Inc. Announces First Closing Date Acceptances under Cash Offer to Acquire Axis Shield PLC
Alere Inc. Announces First Closing Date Acceptances under Cash Offer to Acquire Axis Shield PLC -
Alere Mails Axis Shield Offer Documents
Alere Mails Axis Shield Offer Documents -
Rule 8.1 Announcement re Ownership of Axis-Shield Shares
Rule 8.1 Announcement re Ownership of Axis-Shield Shares
Since its discovery in 1981, HIV has become a global pandemic, with over thirty-three million cases worldwide and more than 2.5 million new cases occurring each year. And, while these figures are staggering, a host of technological advances and scientific breakthroughs have helped make living with HIV more manageable. Alere has been at the forefront of many of these advances, working to provide tools that enable healthcare practitioners to detect the virus and make more informed decisions about the appropriate therapy for diagnosed individuals earlier. The Alere Pima™ CD4 Analyzer, which provides absolute CD4 results in 20 minutes, has been shown to improve access to critical data and decrease the time to antiretroviral therapy initiation in remote corners of the world.